News Article

Ellesmere Port health firms key role in blood test trial

29 September 2021

An Ellesmere Port health firm is to play a key role in the world's largest trial of a revolutionary new blood test.

EMS Healthcare said its expertise has already been hailed as “invaluable” in a process that could revolutionise early cancer screening.

The project will trial a new blood test – which is called Galleri™ and was developed by US firm GRAIL.

The aim is to recruit 140,000 participants in England aged 50-77 with no history of cancer in the last three years.

Participants will be screened for more than 50 types of cancer – including those that are hard to detect in their early stages, such as pancreatic, head and neck, ovarian and oesophageal cancers.

Read more at: Chester Standard